Literature DB >> 2512137

Influenza subtype-specific immunoglobulin A and G responses after booster versus one double-dose vaccination in hemodialysis patients.

P Rautenberg1, D Proppe, A Schütte, U Ullmann.   

Abstract

The antibody response in hemodialysis patients was studied after one double dose of influenza vaccine versus one conventional dose plus a booster dose five weeks later. The influenza virus subtype specific IgA and IgG responses were recorded by means of an indirect immunofluorescence assay over a period of 20 weeks. Higher antibody titers, higher response rates and a higher rate of development of protective titers after the single double-dose vaccine indicated it was superior to the single dose/booster dose regimen. It is therefore suggested that hemodialysis patients are immunized with a higher dosage of influenza vaccine to achieve better protection rates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512137     DOI: 10.1007/bf01963779

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity.

Authors:  L Chatenoud; B Dugas; G Beaurain; M Touam; T Drueke; A Vasquez; P Galanaud; J F Bach; J F Delfraissy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

2.  Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis.

Authors:  D J Versluis; W E Beyer; N Masurel; W Weimar; P Kramer; P P Diderich
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

3.  Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination.

Authors:  P Rautenberg; I Teifke; T Schlegelberger; U Ullmann
Journal:  Infection       Date:  1988       Impact factor: 3.553

4.  Immunogenicity of inactivated influenza virus vaccine in chronic renal failure.

Authors:  M C Jordan; W E Rousseau; G E Tegtmeier; G R Noble; R G Muth; T D Chin
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

5.  Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine.

Authors:  D J Versluis; W E Beyer; N Masurel; G J Wenting; W Weimar
Journal:  Transplantation       Date:  1986-10       Impact factor: 4.939

6.  Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination.

Authors:  R Cappel; D Van Beers; C Liesnard; M Dratwa
Journal:  Nephron       Date:  1983       Impact factor: 2.847

7.  Low-dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination.

Authors:  S C Meuer; H Dumann; K H Meyer zum Büschenfelde; H Köhler
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

8.  Antibody responses to influenza vaccination in patients with chronic renal failure.

Authors:  E O Osanloo; B S Berlin; S Popli; T S Ing; J E Cummings; V C Gandhi; W P Geis; J E Hano
Journal:  Kidney Int       Date:  1978-12       Impact factor: 10.612

9.  Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.

Authors:  C E Stevens; H J Alter; P E Taylor; E A Zang; E J Harley; W Szmuness
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

10.  Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.

Authors:  S C Meuer; M Hauer; P Kurz; K H Meyer zum Büschenfelde; H Köhler
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

View more
  4 in total

Review 1.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

2.  High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis.

Authors:  Dana C Miskulin; Daniel E Weiner; Hocine Tighiouart; Eduardo K Lacson; Klemens B Meyer; Taimur Dad; Harold J Manley
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-23       Impact factor: 8.237

3.  Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.

Authors:  Georg Beilhack; Rossella Monteforte; Florian Frommlet; Martina Gaggl; Robert Strassl; Andreas Vychytil
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

4.  Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.

Authors:  Behdad Afzali; Francis C Edozie; Henrieta Fazekasova; Cristiano Scottà; Peter J Mitchell; James B Canavan; Shahram Y Kordasti; Prabhjoat S Chana; Richard Ellis; Graham M Lord; Susan John; Rachel Hilton; Robert I Lechler; Giovanna Lombardi
Journal:  Clin J Am Soc Nephrol       Date:  2013-04-11       Impact factor: 8.237

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.